Stacy Loeb, MD discusses how the decision for prostate cancer screening should be an individual one, rather than population-based. Individual risk factors including age, general health, family history, etc are all important to consider. While the results from the ERSPC trial do show better outcomes for those...

With the continual advancement of technology in surgery, one would expect that robotic prostatectomy to be the gold standard of treatment for prostate cancer. However, Judd Moul, MD, explains the reasons why open surgery is still superior to robotic surgery. Reference: Bio for Judd Moul, MD Faculty and...

Janna Andrews, MD takes us for a tour of the latest technological advancements in the field of radiation therapy delivery for prostate cancer treatment. She explains the benefits of Intensity-Modulated Radiation Therapy, which include increased dosage of targeted structures, decreased toxicity, and the...